Drug class
Tetracyclic antidepressant; predominantly norepinephrine reuptake inhibitor
Mechanism of action
Inhibits neuronal reuptake of norepinephrine, increasing noradrenergic neurotransmission. It also has antihistaminic and anticholinergic receptor effects contributing to sedation and adverse effects.
General use cases
- Historical treatment of depressive illness in adults in countries where maprotiline remains authorised; current availability is limited and product-specific indications should be verified
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
